These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34840594)

  • 1. Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma.
    Tang X; Miao Y; Wang J; Cai T; Yang L; Mi D
    Comput Math Methods Med; 2021; 2021():1205029. PubMed ID: 34840594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma.
    Huang DP; Liao MM; Tong JJ; Yuan WQ; Peng DT; Lai JP; Zeng YH; Qiu YJ; Tong GD
    Aging (Albany NY); 2021 Nov; 13(22):24621-24639. PubMed ID: 34799469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.
    Jin C; Zhao JS; Huang XQ; Yang XZ; Niu FY; Lin JR; Ma L; Shi YX; Li XS; Jiang P; Gao S; Li F; Song Y
    Hepatol Int; 2022 Oct; 16(5):1220-1233. PubMed ID: 35947245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer.
    Bao S; Zhao H; Yuan J; Fan D; Zhang Z; Su J; Zhou M
    Brief Bioinform; 2020 Sep; 21(5):1742-1755. PubMed ID: 31665214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma.
    Zhu J; Huang Q; Liu S; Peng X; Xue J; Feng T; Huang W; Chen Z; Lai K; Ji Y; Wang M; Yuan R
    Front Immunol; 2022; 13():856186. PubMed ID: 35479067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L; Xie R; Lu G
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks.
    Yu X; Zhang J; Yang R; Li C
    Biomed Res Int; 2020; 2020():8579651. PubMed ID: 33299877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of N
    Zhu HX; Lu WJ; Zhu WP; Yu S
    J Clin Lab Anal; 2021 Dec; 35(12):e24071. PubMed ID: 34741346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma.
    Xu Q; Wang Y; Huang W
    Int Immunopharmacol; 2021 Mar; 92():107333. PubMed ID: 33486322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma.
    Zhang Q; Ning G; Jiang H; Huang Y; Piao J; Chen Z; Tan X; Zhang J; Liu G
    Dis Markers; 2020; 2020():9180732. PubMed ID: 33520012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.
    Jiao Y; Li S; Wang X; Yi M; Wei H; Rong S; Zheng K; Zhang L
    Front Immunol; 2022; 13():929846. PubMed ID: 35990656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A computational prognostic model of lncRNA signature for clear cell renal cell carcinoma with genome instability.
    Cui T; Guo J; Sun Z
    Expert Rev Mol Diagn; 2022 Feb; 22(2):213-222. PubMed ID: 34871123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.
    Wu H; Zhang ZY; Zhang Z; Xiao XY; Gao SL; Lu C; Zuo L; Zhang LF
    Bioengineered; 2021 Dec; 12(1):1725-1738. PubMed ID: 33955803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
    Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
    Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.